By the Leanova Research Team Photo credit: Gaurav Rai / Pexels Your annual health check flags one line: HbA1c 6.2%. Or 5.8%, or 6.4%. The report says "prediabetes" or "borderline", your fasting sugar looks almost normal, and nobody has told you what to do next. Start tablets? Cut out rice? Recheck next year? You are far from alone. "How do I lower my A1C?" and "Is prediabetes reversible?" are among the most common health questions people search, in India and worldwide. This article explains what an HbA1c of 5.7 to 6.4 means, what Indian and international trials show about bringing it back to normal, how much weight loss helps, how long it takes, and when a doctor may add medicines. First, what is HbA1c, and what is the normal range? HbA1c (also written A1C or glycated haemoglobin) measures how much of the haemoglobin in your red blood cells has glucose attached. Because red blood cells live about three months, HbA1c reflects your average blood sugar over the past two to three months. One good week before the test does not change it much. The standard cut-offs, used by the American Diabetes Association (ADA) and the US National Library of Medicine, are: HbA1c result | What it usually means Below 5.7% | Normal range 5.7% to 6.4% | Prediabetes (higher than normal, not yet diabetes) 6.5% or higher | Diabetes range (usually confirmed with a repeat test or a second test) So an HbA1c of 6.2 sits in the middle-to-upper part of the prediabetes range. An HbA1c of 5.8 or 5.9 is at the lower end. Neither is a diagnosis of diabetes, but both are a signal. A few practical points matter in India: • One test is not the whole story. Doctors often add a fasting glucose or an oral glucose tolerance test (the "sugar drink" test). • Anaemia and some blood disorders can make HbA1c unreliable. Iron deficiency and thalassaemia trait are common in India, and kidney or liver disease can also affect results. If HbA1c and glucose readings do not match, tell your doctor. • Higher within the range means higher risk. The ADA 2026 Standards of Care single out people with an HbA1c of 6.0% or above, fasting glucose of 110 to 125 mg/dL, a BMI of 35 or more, or a history of diabetes in pregnancy as being at particularly high risk of progressing to type 2 diabetes, and suggest more intensive prevention for them. How common is prediabetes in India? Very common, and often unnoticed. The ICMR-INDIAB national survey of more than 113,000 adults across 31 states and union territories (Anjana RM et al., Lancet Diabetes & Endocrinology, 2023) found that about 15.3% of Indian adults have prediabetes and 11.4% have diabetes, roughly 136 million and 101 million people. Unlike diabetes, prediabetes was not more common in cities than villages, and in many less-developed states it outnumbered diabetes, a sign of the next wave. Workplace data agree. Loop Health's India Workforce Health Index 2026 analysed 7,088 HbA1c reports from employees and families: 25.4% were in the prediabetes range and 13.3% in the diabetes range. Elevated results rose from one in six reports in people's 20s to one in three in their 30s. The prediabetes-range share was 22.5% in Hyderabad, 20.4% in Bengaluru, 19.7% in Delhi NCR, and around 30% in Mumbai and Pune. These are tested, insured groups, not population estimates, but they show how many working Indians carry a borderline HbA1c. Practo also reported that diabetes searches on its platform doubled between 2023 and 2025. Can prediabetes be reversed to a normal HbA1c? For many people, yes, prediabetes can return to the normal range, and the evidence that this matters is strong. But "reversal" is not a one-time cure, and it does not happen for everyone. The Indian evidence: Indian Diabetes Prevention Programme (IDPP-1) The IDPP-1 trial in Chennai randomised 531 Indian adults with impaired glucose tolerance (prediabetes found on the sugar drink test). They were relatively young (average age about 46) and not very heavy (average BMI about 25.8), typical of how diabetes develops in Indians at lower body weights. Over three years, diabetes developed in 55% of the control group, compared with 39.3% of those given lifestyle advice and 40.5% of those given metformin. That is a relative risk reduction of about 28.5% with lifestyle change and 26.4% with metformin. Combining the two gave no extra benefit. The authors concluded that progression from prediabetes to diabetes is high in Asian Indians, and that both approaches significantly reduced it. Two lessons stand out: without change, more than half of these adults developed diabetes within three years; and even modest lifestyle advice, in people who were not obese by Western standards, made a real difference. The landmark US trial: Diabetes Prevention Program (DPP) The DPP enrolled 3,234 adults with raised fasting and post-meal glucose (average BMI 34). The lifestyle group aimed for at least 7% weight loss and at least 150 minutes of physical activity a week. Over about three years, the lifestyle programme cut new cases of diabetes by 58%, and metformin by 31%, compared with placebo. Getting back to normal, even once, lowers future risk A follow-up analysis of the DPP looked at people who returned to normal glucose levels at least once during the trial. Their risk of developing diabetes in later years was 56% lower than in people who stayed in the prediabetes range, regardless of which treatment they had received. The ADA 2026 Standards also note that reaching normal glucose, even once, was linked with fewer small-vessel complications later. In plain words: bringing your HbA1c back below 5.7% is worth aiming for, and it counts even if it later drifts. How much weight loss lowers HbA1c and diabetes risk? This is the question most people really want answered. • Every kilogram counts. In the DPP lifestyle group, weight loss was the single strongest predictor of avoiding diabetes. For every 1 kg lost, diabetes risk fell by about 16% over roughly three years, after accounting for changes in diet and activity. The researchers estimated that a 5 kg loss could account for about a 55% lower risk. • The target most guidelines use is 5 to 7% of body weight. For a person weighing 80 kg, that is about 4 to 5.5 kg. The ADA 2026 Standards recommend referring adults with overweight or obesity at high risk of type 2 diabetes to a structured programme to achieve and keep off at least 5 to 7% of their starting weight, with 150 minutes or more of moderate activity a week, and note that 7 to 10% loss may give greater benefit. • Activity helps even if the scale is slow. Among DPP participants who did not reach the weight goal at one year, those who still met the 150-minute activity goal had 44% lower diabetes incidence. The UK DiRECT trial shows how tightly weight and blood sugar are linked, even after diabetes has started. Adults diagnosed with type 2 diabetes within six years followed a supervised low-calorie programme; at 12 months 46% achieved remission (HbA1c below 6.5% off all diabetes medicines). Remission occurred in 7% of those who lost up to 5 kg, 34% with 5 to 10 kg, 57% with 10 to 15 kg, and 86% with 15 kg or more. DiRECT was a diabetes trial using a medically supervised meal-replacement diet that should not be copied at home, but the principle holds: more weight lost and kept off usually means better blood sugar.
Realistic timelines: when will my HbA1c come down? Because HbA1c reflects about three months of blood sugar, it changes slowly. Time from starting changes | What is realistic First 2 to 4 weeks | Post-meal and fasting glucose readings may improve first; HbA1c will have barely moved Around 3 months | First meaningful repeat HbA1c; many clinicians recheck at about this point after making changes 6 to 12 months | Clearer picture of whether you have returned to the normal range and are keeping weight off Every year after | The ADA advises people with prediabetes to be checked for diabetes at least once a year, more often if risk is higher A drop from 6.2% to 5.9% is real progress even if you are not yet below 5.7%. No timeline is guaranteed; age, family history, starting weight, sleep, other medicines and insulin resistance all affect the result. What works in an Indian kitchen and an Indian day The ADA 2026 Standards say there is no single ideal ratio of carbohydrate, protein and fat; Mediterranean-style, plant-based, DASH and lower-carbohydrate patterns can all work if overall quality is good: more whole grains, legumes, nuts, vegetables and fruit, fewer refined and processed foods. In everyday Indian meals: • Shrink the starch, not the meal. White rice, refined flour and large stacks of wheat flatbreads are the main calorie source for many families. Halve that portion and fill the space with vegetables and protein. • Add protein to every meal. Lentils, chickpeas, kidney beans, curd, cottage cheese, eggs, fish or chicken keep you full and protect muscle. • Watch liquid sugar and snacks. Sweetened tea several times a day, packaged juices, biscuits and fried savoury snacks add up quickly. "Sugar-free" products are often still high in refined flour and fat. • Walk after meals and break up sitting. The ADA notes that interrupting long sitting lowers post-meal glucose. A 10 to 15 minute walk after lunch and dinner suits desk workers in Bengaluru, Hyderabad or Delhi. • Build to 150 minutes a week, such as 30 minutes of brisk walking on five days, plus strength work (squats, stairs, resistance bands) twice a week. • Protect your sleep. The ADA links sleeping under about 6 hours or over about 9 hours with up to 50% higher risk of type 2 diabetes, including progression from prediabetes. Avoid crash diets, unproven "HbA1c-lowering" powders, and any plan that tells you to stop prescribed medicines. When do medicines come in? Lifestyle change is the foundation, but it is not always enough, especially when weight is high or HbA1c is creeping towards 6.5%. Medicines are a decision made with a registered physician after reviewing your full picture. Metformin has the longest track record for diabetes prevention. The ADA 2026 Standards say it should be considered for high-risk adults, especially those aged 25 to 59 with a BMI of 35 or more, fasting glucose of 110 mg/dL or more, HbA1c of 6.0% or more, or past diabetes in pregnancy. In IDPP-1 it lowered risk about as much as lifestyle advice. Stomach upset and loose stools are common, and long-term use can lower vitamin B12, so periodic B12 checks are advised. GLP-1-based medicines (such as semaglutide and tirzepatide) are prescription weight-management and diabetes medicines. In the STEP 1 trial, among adults with obesity or overweight and prediabetes, 84.1% on semaglutide 2.4 mg had normal glucose levels at 68 weeks versus 47.8% on placebo, with both groups also receiving lifestyle support (this was an exploratory analysis). In the three-year SURMOUNT-1 analysis of adults with obesity and prediabetes, 1.3% of those on tirzepatide developed type 2 diabetes versus 13.3% on placebo. After 17 weeks off treatment the figures were 2.4% versus 13.7%, and some of the improvement was lost. Be precise about what this means: • They are not approved specifically to treat prediabetes or prevent diabetes. The ADA 2026 Standards say there are no long-term data supporting medicines other than metformin solely for diabetes prevention, but that GLP-1-based therapy for weight management in people with overweight or obesity is highly beneficial and should be considered. • They are for people who meet weight-management criteria, not for anyone with a borderline HbA1c and a healthy weight. • Side effects are real. Nausea, vomiting, diarrhoea and constipation are common, usually mild to moderate and mostly during dose increases. Less common risks such as gallbladder problems and pancreatitis need follow-up. They are not for use in pregnancy or in people with certain thyroid tumour histories. • Benefits tend to fade after stopping, so this is a long-term decision, including on cost. Never buy injections online without a prescription. When to see a doctor Book a consultation if: • Your HbA1c is 6.0% or higher, or has risen on two consecutive tests • You have a family history of type 2 diabetes, or high blood pressure, high cholesterol, fatty liver, PCOS, or past diabetes in pregnancy • Your waist is growing even if your weight looks "fine" by Western charts • Your HbA1c and glucose readings do not match, or you have anaemia • Several months of diet and exercise have not moved your numbers Prediabetes is also linked with higher heart risk, so a good review checks blood pressure, cholesterol and smoking too. How Leanova can help Leanova is a metabolic health practice led by registered physicians. For people with a prediabetes-range HbA1c, we start with the full picture: confirmatory tests where needed, waist and weight, blood pressure, lipids, liver markers, sleep, work patterns and food habits. We build a realistic plan around Indian meals with rechecks at about three months, and discuss medicines such as metformin or GLP-1-based therapy only when they genuinely fit, with balanced information on benefits, side effects and cost. We support patients across India through teleconsultation, including Hyderabad and Telangana, Bengaluru, Delhi, Chandigarh and Maharashtra.
Message us on WhatsApp at +91 93633 43330, email care@leanova.in, or visit leanova.in. Frequently asked questions Is HbA1c 6.2 dangerous? An HbA1c of 6.2% is in the prediabetes range (5.7 to 6.4%). It is not diabetes, but your risk of type 2 diabetes and heart disease is raised, and values of 6.0% and above are considered higher risk. It is a reason to act, not to panic. What is the normal range of HbA1c? Below 5.7% is normal, 5.7% to 6.4% is prediabetes, and 6.5% or above is the diabetes range, usually confirmed with a second test. Anaemia, blood disorders, kidney or liver disease and pregnancy can affect interpretation. Can prediabetes be reversed permanently? Many people return to a normal HbA1c, and in the Diabetes Prevention Program those who reached normal glucose even once had a 56% lower risk of later diabetes. But the underlying tendency remains, so results last only as long as the habits and weight loss behind them. Keep checking yearly. How much weight do I need to lose to lower my HbA1c? Guidelines suggest aiming for at least 5 to 7% of your body weight, and 7 to 10% may give more benefit. In the DPP, each kilogram lost lowered diabetes risk by about 16%. The exact HbA1c drop varies from person to person, and no specific number can be promised. How fast can I reduce my HbA1c? HbA1c reflects two to three months of blood sugar, so a meaningful repeat test is usually done after about three months. Be wary of anyone promising to reverse high sugar in 30 days. Should I start metformin or a weight-loss injection for prediabetes? Not automatically. Metformin is considered for higher-risk groups (for example BMI 35 or more, HbA1c 6.0% or more, or past diabetes in pregnancy). GLP-1-based medicines such as semaglutide or tirzepatide are weight-management medicines for people who meet obesity or overweight criteria, not approved specifically for prediabetes. Decide with a registered physician. References 1. American Diabetes Association Professional Practice Committee. 3. Prevention or Delay of Diabetes and Associated Comorbidities: Standards of Care in Diabetes—2026. Diabetes Care. 2026;49(Suppl 1):S50–S60. https://diabetesjournals.org/care/article/49/Supplement_1/S50/163924/3-Prevention-or-Delay-of-Diabetes-and-Associated 2. MedlinePlus (US National Library of Medicine). Hemoglobin A1C (HbA1c) Test. https://medlineplus.gov/lab-tests/hemoglobin-a1c-hba1c-test/ 3. Anjana RM, Unnikrishnan R, Deepa M, et al. Metabolic non-communicable disease health report of India: the ICMR-INDIAB national cross-sectional study (ICMR-INDIAB-17). Lancet Diabetes Endocrinol. 2023;11(7):474–489. https://pubmed.ncbi.nlm.nih.gov/37301218/ 4. Loop Health. Blood Sugar. India Workforce Health Index 2026. https://whi.loophealth.com/risk-signals/blood-sugar/ 5. Fortune India. Online queries on lifestyle diseases show significant jump in India, says Practo. https://www.fortuneindia.com/business-news/online-queries-on-lifestyle-diseases-shows-significant-jump-in-india-says-practo/131976 6. Ramachandran A, Snehalatha C, Mary S, et al. The Indian Diabetes Prevention Programme shows that lifestyle modification and metformin prevent type 2 diabetes in Asian Indian subjects with impaired glucose tolerance (IDPP-1). Diabetologia. 2006;49(2):289–297. https://pubmed.ncbi.nlm.nih.gov/16391903/ 7. Knowler WC, Barrett-Connor E, Fowler SE, et al. Reduction in the incidence of type 2 diabetes with lifestyle intervention or metformin. N Engl J Med. 2002;346(6):393–403. https://pubmed.ncbi.nlm.nih.gov/11832527/ 8. Hamman RF, Wing RR, Edelstein SL, et al. Effect of weight loss with lifestyle intervention on risk of diabetes. Diabetes Care. 2006;29(9):2102–2107. https://diabetesjournals.org/care/article/29/9/2102/24174/Effect-of-Weight-Loss-With-Lifestyle-Intervention 9. Perreault L, Pan Q, Mather KJ, et al. Effect of regression from prediabetes to normal glucose regulation on long-term reduction in diabetes risk: results from the Diabetes Prevention Program Outcomes Study. Lancet. 2012;379(9833):2243–2251. https://pubmed.ncbi.nlm.nih.gov/22683134/ 10. Lean MEJ, Leslie WS, Barnes AC, et al. Primary care-led weight management for remission of type 2 diabetes (DiRECT): an open-label, cluster-randomised trial. Lancet. 2018;391(10120):541–551. https://pubmed.ncbi.nlm.nih.gov/29221645/ 11. Perreault L, Davies M, Frias JP, et al. Changes in glucose metabolism and glycemic status with once-weekly subcutaneous semaglutide 2.4 mg among participants with prediabetes in the STEP program. Diabetes Care. 2022;45(10):2396–2405. https://diabetesjournals.org/care/article/45/10/2396/147113/Changes-in-Glucose-Metabolism-and-Glycemic-Status 12. Jastreboff AM, le Roux CW, Stefanski A, et al. Tirzepatide for obesity treatment and diabetes prevention (SURMOUNT-1, 3-year analysis). N Engl J Med. 2025;392:958–971. https://www.nejm.org/doi/full/10.1056/NEJMoa2410819 13. The Times of India. Most Googled health questions of 2025. https://timesofindia.indiatimes.com/life-style/health-fitness/most-googled-health-questions-of-2025/articleshow/126270329.cms Disclaimer: This article is for general education only and is not a substitute for personal medical advice, diagnosis or treatment. HbA1c and glucose results, prediabetes, type 2 diabetes, weight-loss programmes and medicines (including metformin, semaglutide and tirzepatide) should be interpreted and managed only under the guidance of a registered physician. GLP-1-based medicines are prescription medicines for approved indications and are not approved specifically for prediabetes. Do not start, stop or change any medicine on your own. Individual results vary; a return to normal HbA1c, weight loss or diabetes prevention cannot be guaranteed, and benefits may fade if lifestyle changes or treatment stop.